Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve {TAIL ~ therapeutic reduction} of the number of {HEAD ~ circulating platelets} 
Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve { TAIL ~ therapeutic reduction } of the number of { HEAD ~ circulating platelets }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD